Literature DB >> 8671638

Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo.

M F Krummel1, T J Sullivan, J P Allison.   

Abstract

Co-stimulation via the CD28/CTLA-4 system appears critical for T cell proliferation to peptide antigens presented in association with MHC. In this study, we examine the roles of CD28 and CTLA-4 in the response of murine T cells to the superantigen staphylococcal enterotoxin B (SEB). In vitro, antibodies against B7-1/B7-2 or Fab fragments of anti-CD28 antibodies significantly inhibit the response of splenocytes to SEB. Conversely, Fab fragments of anti-CTLA-4 antibodies augment the proliferative response. Further, addition of blocking antibodies directed against B7-1/B7-2 augment proliferation co-stimulated by intact anti-CD28 antibodies. These data support the hypothesis that CD28 and CTLA-4 exert opposing effects upon early T cell activation. In vivo, intact anti-CD28 antibodies and non-stimulatory Fab fragments of anti-CD28 appear to have similar inhibitory effects upon the expansion of V beta 8+ T cells. In contrast, both intact and Fab fragments of anti-CTLA-4 appear to amplify this expansion. We conclude that the SEB response is significantly augmented by CD28-derived signaling and this in turn may be attenuated by signals through CTLA-4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8671638     DOI: 10.1093/intimm/8.4.519

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  36 in total

1.  Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Authors:  E D Kwon; A A Hurwitz; B A Foster; C Madias; A L Feldhaus; N M Greenberg; M B Burg; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Differentiation-dependent differences in murine T cell susceptibility to negative regulation by the lung.

Authors:  Rhea Y Busick; Rama D Yammani; Martha A Alexander-Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2011-01-07       Impact factor: 6.914

3.  Transcytosis route mediates rapid delivery of intact antibodies to draining lymph nodes.

Authors:  Laura Kähäri; Ruth Fair-Mäkelä; Kaisa Auvinen; Pia Rantakari; Sirpa Jalkanen; Johanna Ivaska; Marko Salmi
Journal:  J Clin Invest       Date:  2019-06-24       Impact factor: 14.808

Review 4.  Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.

Authors:  Damir Bojadzic; Peter Buchwald
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

5.  In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance.

Authors:  E M Sotomayor; I Borrello; E Tubb; J P Allison; H I Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 6.  Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?

Authors:  Chethan Ramamurthy; James L Godwin; Hossein Borghaei
Journal:  Curr Treat Options Oncol       Date:  2017-06

Review 7.  Ipilimumab: from preclinical development to future clinical perspectives in melanoma.

Authors:  Paul Letendre; Varun Monga; Mohammed Milhem; Yousef Zakharia
Journal:  Future Oncol       Date:  2016-11-24       Impact factor: 3.404

8.  CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.

Authors:  Josef Kurtz; Forum Raval; Casey Vallot; Jayden Der; Megan Sykes
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

9.  A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

Authors:  Susan M Hiniker; Daniel S Chen; Sunil Reddy; Daniel T Chang; Jennifer C Jones; Joseph A Mollick; Susan M Swetter; Susan J Knox
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

10.  CTLA-4 blockade inhibits induction of Helicobacter pylori-associated gastritis in mice.

Authors:  K Watanabe; K Murakami; R Sato; T Okimoto; K Maeda; M Nasu; A Nishizono; T Fujioka
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.